Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population.
Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population. Patient Prefer Adherence. 2019; 13:1545-1556.